Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.

Takeru WakatsukiNaoki IshizukaShuichi HironakaKeiko MinashiShigenori KadowakiMasahiro GotoHirokazu ShojiHidekazu HiranoIzuma NakayamaHiroki OsumiMariko OguraKeisho ChinKensei YamaguchiDaisuke Takahari

Published in: International journal of clinical oncology (2024)

Baseline sHER2 ECD levels and its early decline may be useful biomarkers for SOX plus trastuzumab efficacy in HER2 positive gastric cancer.

Keyphrases

epidermal growth factor receptor
transcription factor
stem cells
metastatic breast cancer
tyrosine kinase